FDA clears sustained-release implant for noninfectious uveitis

• Posted on: Oct 16 2018
• By: Saratoga Opthalmology
• Leave a response

EyePoint Pharmaceuticals has received FDA approval for Yutiq, an intravitreal fluocinolone acetonide insert for patients with chronic non-infectious posterior uveitis.
Source: AAO

Posted in: Uncategorized